Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 20/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22654569 | 1.00 | PIK3C3 (0.69) | PIK3C3 | |
| SCHEMBL22654572 | 1.00 | PIK3C3 (0.69) | PIK3C3 | |
| SCHEMBL30288864 | 1.00 | PIK3C3 (0.69) | PIK3C3 | |
| SCHEMBL20765405 | 0.90 | PIK3C3 (0.72) | PIK3C3 | |
| SCHEMBL22654565 | 0.90 | PIK3C3 (0.72) | PIK3C3 | |
| SCHEMBL29633708 | 0.90 | PIK3C3 (0.72) | PIK3C3 | |
| SCHEMBL20777027 | 0.88 | PIK3C3 (0.69) | PIK3C3 | |
| SCHEMBL24470269 | 0.82 | PIK3C3 (1.00) | PIK3C3 | |
| SCHEMBL19272649 | 0.82 | PIK3C3 (1.00) | PIK3C3 | |
| SCHEMBL19259530 | 0.82 | PIK3C3 (1.00) | PIK3C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384180-A1 | COMBINATION THERAPY OF VPS34 INHIBITORS AND STING AGONIST FOR USE IN THE TREATMENT OF CANCER | Deciphera Pharmaceuticals, LLC (US) | 2024-06-19 | — | — | EP | claimed |
| EP-4251165-A1 | MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION | Deciphera Pharmaceuticals, LLC (US) | 2023-10-04 | — | — | EP | claimed |
| WO-2023019259-A1 | COMBINATION THERAPY OF VPS34 INHIBITORS AND STING AGONIST FOR USE IN THE TREATMENT OF CANCER | DECIPHERA PHARMACEUTICALS, LLC (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2022115558-A1 | MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION | DECIPHERA PHARMACEUTICALS, LLC (US) | 2022-06-02 | — | — | WO | claimed |
| EP-4251165-A1 | MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION | Deciphera Pharmaceuticals, LLC (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-2022115558-A1 | MORPHOLINO DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION | DECIPHERA PHARMACEUTICALS, LLC (US) | 2022-06-02 | — | — | WO | disclosed |